Metopran

Metoclopramide Hydrochloride, the active ingredient in Metopran, is a dopamine antagonist / antiemetic presented as an oral dosage form for oral use. It is used to treat nausea, vomiting, gastroparesis and gastro‑oesophageal reflux disease in adults.

GNH USA supplies Metopran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the central chemoreceptor trigger zone and gastrointestinal motility to relieve symptoms in several disorders.

- Nausea and vomiting: reduces the frequency and severity of episodes in patients with acute, postoperative or chemotherapy‑induced nausea. - Gastroparesis: enhances gastric emptying and improves related digestive discomfort. - Gastro‑oesophageal reflux disease (GERD): alleviates reflux symptoms by promoting gastric clearance.

Metopran may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Fatigue: general tiredness. - Restlessness: inner sense of unease or agitation. - Diarrhea: loose, watery stools.

Serious or Rare Side Effects: - Extrapyramidal reactions: involuntary muscle movements such as dystonia. - Tardive dyskinesia: persistent, often irreversible facial or tongue movements. - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Depression or suicidal thoughts: mood changes that may require immediate medical attention.

Before prescribing Metopran, clinicians should consider several safety aspects. - Assess renal and hepatic function: dose adjustment may be required in impairment. - Use the lowest effective dose: minimizes risk of extrapyramidal symptoms. - Monitor for movement disorders: watch for early signs of dystonia or tardive dyskinesia. - Avoid in patients with known hypersensitivity to metoclopramide or other dopamine antagonists. - Caution in pregnancy: benefits must outweigh potential risks. - Store at room temperature: keep in the original pack, protect from moisture.

Metopran can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticholinergic agents: may increase constipation and reduce gastrointestinal motility. - CNS depressants (e.g., opioids, benzodiazepines): can enhance sedation and respiratory depression. - MAO inhibitors: may potentiate central nervous system effects.

Moderate Interactions (Monitor Closely): - CYP2D6 substrates (e.g., metoprolol): metoclopramide may alter their plasma concentrations. - Antidepressants (SSRIs, SNRIs): combined use can raise the risk of serotonin syndrome.